Evidence map›Paper›PMID 37978513›Full record

ArticleJournal of translational medicine2023

Long read sequencing characterises a novel structural variant, revealing underactive AKR1C1 with overactive AKR1C2 as a possible cause of severe chronic fatigue.

Julia Oakley, Martin Hill, Adam Giess, Mélanie Tanguy, Greg Elgar

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Julia OakleyIndependent researcher, Hampshire, UK.ORCID 0000-0002-4768-0192
Martin HillDepartment of Steroids and Proteofactors, Institute of Endocrinology, Národni 8, 11694, Prague, Czech Republic.ORCID 0000-0002-1705-0835
Adam GiessScientific Research and Development, Genomics England, London, UK.ORCID 0000-0003-1683-2146
Mélanie TanguyScientific Research and Development, Genomics England, London, UK.ORCID 0000-0003-4862-0981
Greg ElgarScientific Research and Development, Genomics England, London, UK. Greg.Elgar@genomicsengland.co.uk.ORCID 0000-0001-7323-1596
Genomics England · GBInstitute of Endocrinology · CZOldham Council · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundCausative genetic variants cannot yet be found for many disorders with a clear heritable component, including chronic fatigue disorders like myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). These conditions may involve genes in difficult-to-align genomic regions that are refractory to short read approaches. Structural variants in these regions can be particularly hard to detect or define with short reads, yet may account for a significant number of cases. Long read sequencing can overcome these difficulties but so far little data is available regarding the specific analytical challenges inherent in such regions, which need to be taken into account to ensure that variants are correctly identified. Research into chronic fatigue disorders faces the additional challenge that the heterogeneous patient populations likely encompass multiple aetiologies with overlapping symptoms, rather than a single disease entity, such that each individual abnormality may lack statistical significance within a larger sample. Better delineation of patient subgroups is needed to target research and treatment.

methodsWe use nanopore sequencing in a case of unexplained severe fatigue to identify and fully characterise a large inversion in a highly homologous region spanning the AKR1C gene locus, which was indicated but could not be resolved by short-read sequencing. We then use GC-MS/MS serum steroid analysis to investigate the functional consequences.

resultsSeveral commonly used bioinformatics tools are confounded by the homology but a combined approach including visual inspection allows the variant to be accurately resolved. The DNA inversion appears to increase the expression of AKR1C2 while limiting AKR1C1 activity, resulting in a relative increase of inhibitory GABAergic neurosteroids and impaired progesterone metabolism which could suppress neuronal activity and interfere with cellular function in a wide range of tissues.

conclusionsThis study provides an example of how long read sequencing can improve diagnostic yield in research and clinical care, and highlights some of the analytical challenges presented by regions containing tandem arrays of genes. It also proposes a novel gene associated with a novel disease aetiology that may be an underlying cause of complex chronic fatigue. It reveals biomarkers that could now be assessed in a larger cohort, potentially identifying a subset of patients who might respond to treatments suggested by the aetiology.

Indexed as

Fatigue Syndrome, Chronic3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)BiomarkersHumansHydroxysteroid DehydrogenasesTandem Mass Spectrometry3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)AKR1C2 protein, humanBiomarkersHydroxysteroid DehydrogenasesAKR1C1AKR1C2AllopregnanoloneFatigueLong read sequencingME/CFS diagnosisNeurosteroidsStructural variants

Identifiers

PMID37978513
PMCPMC10655400
OpenAlexW4388767767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.